Detalles de la búsqueda
1.
Efficacy of Icotinib, an EGFR Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients with Exon 19 Deletion and Exon 21 L858R: A Retrospective Analysis in China.
Pharmacology
; 106(11-12): 658-666, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34673645
2.
Phylogenetic analysis of upland cotton MATE gene family reveals a conserved subfamily involved in transport of proanthocyanidins.
Mol Biol Rep
; 46(1): 161-175, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30467666
3.
A putative molybdate transporter LjMOT1 is required for molybdenum transport in Lotus japonicus.
Physiol Plant
; 158(3): 331-340, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27535112
4.
Application of the ESMO Magnitude of Clinical Benefit Scale to assess the clinical benefit of antibody drug conjugates in solid cancer: a systematic descriptive analysis of phase III and pivotal phase II trials.
BMJ Open
; 14(6): e077108, 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38851227
5.
Ensartinib in the treatment of anaplastic lymphoma kinase-positive locally advanced or metastatic patients with lung squamous or adenosquamous carcinoma: A real-world, retrospective study.
Asia Pac J Clin Oncol
; 2024 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38898784
6.
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study.
Cancer Commun (Lond)
; 44(4): 455-468, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421881
7.
A retrospective study of ensartinib-treated ALK-positive locally advanced or metastatic NSCLC patients in China.
Lung Cancer Manag
; 12(4): LMT61, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38239813
8.
Interferon-gamma and tumor necrosis factor-alpha synergistically enhance the immunosuppressive capacity of human umbilical-cord-derived mesenchymal stem cells by increasing PD-L1 expression.
World J Stem Cells
; 15(8): 787-806, 2023 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37700823
9.
Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial.
EClinicalMedicine
; 57: 101839, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36816343
10.
Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study.
Eye (Lond)
; 37(15): 3228-3233, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37041349
11.
Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity.
Mol Ther Oncolytics
; 24: 577-584, 2022 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35252556
12.
TNF-α augments CXCL10/CXCR3 axis activity to induce Epithelial-Mesenchymal Transition in colon cancer cell.
Int J Biol Sci
; 17(11): 2683-2702, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34345201
13.
Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA Sequencing.
J Thorac Oncol
; 16(5): 827-839, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588113
14.
Molecular cloning, expression analysis and subcellular localization of a Transparent Testa 12 ortholog in brown cotton (Gossypium hirsutum L.).
Gene
; 576(2 Pt 2): 763-9, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26548815
Resultados
1 -
14
de 14
1
Próxima >
>>